Efficacy of HBV booster dose administration in Italian medical students in relation to health determinants

Loreta Tobia; Rocco Francesco Zagà; Antonella Mattei; Claudia Cipollone; Alessia Cipriani; Adalgisa Ilaria Sedile; Leila Fabiani; Serena Bianchi

doi:10.1080/21645515.2024.2439049

Human Vaccines & Immunotherapeutics (Dec 2024)

Efficacy of HBV booster dose administration in Italian medical students in relation to health determinants

Loreta Tobia,
Rocco Francesco Zagà,
Antonella Mattei,
Claudia Cipollone,
Alessia Cipriani,
Adalgisa Ilaria Sedile,
Leila Fabiani,
Serena Bianchi

Affiliations

Loreta Tobia: Department of Life, Health and Environmental Science, University of L’Aquila, L’Aquila, Italy
Rocco Francesco Zagà: Department of Life, Health and Environmental Science, University of L’Aquila, L’Aquila, Italy
Antonella Mattei: Department of Life, Health and Environmental Science, University of L’Aquila, L’Aquila, Italy
Claudia Cipollone: Local Health Authority of Avezzano-Sulmona-L’Aquila, L’Aquila, Italy
Alessia Cipriani: Department of Diagnostic Imaging, Oncological Radiotherapy and Hematology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy
Adalgisa Ilaria Sedile: Department of Life, Health and Environmental Science, University of L’Aquila, L’Aquila, Italy
Leila Fabiani: Department of Life, Health and Environmental Science, University of L’Aquila, L’Aquila, Italy
Serena Bianchi: Department of Life, Health and Environmental Science, University of L’Aquila, L’Aquila, Italy

DOI: https://doi.org/10.1080/21645515.2024.2439049
Journal volume & issue: Vol. 20, no. 1

Abstract

Read online

We evaluated the efficacy of a booster dose of HBV in Italian medical students. We conducted a prospective observational study in students who had received a full course of anti-HBV vaccination for at least 15 y. Those with an anti-HBs titer 100 mIU/mL, between 10 and 100 mIU/mL and 100 mIU/mL, in subjects who had a pre-booster anti-HBs titer between 1.00 and 9.99 mIU/mL (84.38%, 81/96), compared to those with titer 1 mIU/mL and do physical activity.

Published in Human Vaccines & Immunotherapeutics

ISSN: 2164-5515 (Print); 2164-554X (Online)
Publisher: Taylor & Francis Group
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Immunologic diseases. Allergy; Medicine: Therapeutics. Pharmacology
Website: https://www.tandfonline.com/journals/khvi

About the journal

Abstract

Keywords